All Adults on Aspirin
The purpose of this study is to determine the optimal dose of aspirin for secondary prevention in patients with ASCVD.
Principal Investigator: Peter McCullough, MD
Locations: Legacy Heart Center, Baylor Scott & White Heart and Vascular Hospital
Sponsor: Duke University
IRB Number: 016-067
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will not change your care
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.